Page last updated: 2024-11-10

dihydroambazone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dihydroambazone: structure given in first source; RN from Toxlit [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3035541
MeSH IDM0163967

Synonyms (7)

Synonym
dihydroambazone
[4-[2-(diaminomethylidene)hydrazinyl]anilino]thiourea
hydrazinecarbothioamide, 2-(4-(2-(aminoiminomethyl)hydrazino)phenyl)-
dihydroambazon
61566-17-4
4-(thiosemicarbazido)diaminomethylene hydrazinobenzene
DTXSID50210571

Research Excerpts

Overview

Dihydroambazone (DHA) is a water-soluble derivative of the experimental anticancer drug ambazone.

ExcerptReferenceRelevance
"Dihydroambazone (DHA) is a water-soluble derivative of the experimental anticancer drug ambazone. "( Synergistic cytotoxic effect of human recombinant tumor necrosis factor alpha combined with dihydroambazone.
Baumgart, J; Behnke, D; Gase, K; Gutsche, W; Schulze, W; Suehnel, J, 1990
)
1.94

Toxicity

ExcerptReferenceRelevance
" It proved to be toxic at 100 mg/kg body mass."( [Antineoplastic activity and toxicity of dihydroambazone in comparison with ambazone (1,4-benzoquinone-guanylhydrazone-thiosemicarbazone)].
Baumgart, J; Gutsche, W; Härtl, A; Schulze, W, 1990
)
0.54
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.09 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]